Cardiac Pause Verification Using Entropy Metrics
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional cardiac pause detection methods in medical devices are prone to false positive detections due to noise, undersensing, and other artifacts, leading to inappropriate therapies, increased resource usage, and reduced battery life.
Innovation Solution
A medical-device system that includes a physiological event detector to receive information about device-detected cardiac pause episodes and uses a verification algorithm to generate metrics, such as entropy metrics, to verify the presence or absence of cardiac pause, thereby reducing false positive detections.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional R-R interval based cardiac pause detection is used, then cardiac pause episodes can be detected, but false positive detections occur due to noise, artifacts, and undersensing
Solution Approach 1:
The patent segments the cardiac signal into multiple components (P-waves, QRS complexes, T-waves) and analyzes each separately to detect cardiac pause. By dividing the detection task into multiple signal component analyses, the system achieves more reliable detection while reducing false positives caused by noise in any single component.
Solution Approach 2:
The patent introduces an intermediary verification process that checks multiple signal characteristics (P-wave absence, QRS absence, T-wave absence) before confirming a cardiac pause episode. This intermediary layer of verification acts as a mediator between raw signal detection and final pause confirmation, filtering out false positives.
2Productivity
If device-based detection algorithms are used to detect cardiac pause episodes, then pause detection is achieved, but false positive events increase clinician burden and reduce review efficiency
Solution Approach 1:
The patent performs preliminary verification of detected pause episodes using multiple signal characteristics before presenting them to clinicians. By conducting this preliminary filtering action beforehand, the system reduces the number of false positive events that require clinician review, thereby improving productivity and reducing time loss.
Solution Approach 2:
The patent implements a feedback mechanism where the detection algorithm continuously refines its performance based on verified pause episodes and false positive patterns. This feedback loop improves the algorithm's ability to distinguish true pause events from artifacts, reducing clinician burden over time.
3Reliability
If conventional pause detection is used, then cardiac pause can be identified, but inappropriate therapies may be delivered due to false positive detections
Solution Approach 1:
The patent applies beforehand cushioning by implementing multiple verification checks before confirming a cardiac pause episode. The system checks for absence of P-waves, QRS complexes, and T-waves, and verifies signal quality metrics in advance, cushioning against the harmful effect of inappropriate therapy delivery by filtering out false positives before therapy decision.
Solution Approach 2:
The patent introduces an intermediary verification process that analyzes multiple signal characteristics between the initial pause detection and the final therapy decision. This intermediary layer prevents inappropriate therapies by filtering out false positive detections through comprehensive signal analysis.
4Productivity
If R-R interval measurement is used for pause detection, then pause episodes can be detected, but noise and artifacts cause false positive detections
Solution Approach 1:
The patent segments the detection process into multiple independent analyses: P-wave detection, QRS complex detection, and T-wave detection. Each segment is analyzed separately for the presence or absence of expected waveforms, and only when all segments confirm absence does the system detect a cardiac pause. This segmentation improves reliability by distributing the detection burden across multiple independent checks.
Solution Approach 2:
The patent changes the detection parameters from simple R-R interval measurement to multi-parameter analysis including P-wave amplitude, QRS complex morphology, T-wave characteristics, and signal quality metrics. By changing from a single parameter to multiple parameters, the system maintains high productivity while improving detection accuracy and reducing false positives.
Data Source
AI summary
Systems and methods for verifying cardiac pause episodes detected by a medical device are disclosed. A medical-device system comprises a physiological event detector to receive information about a cardiac pause episode detected by a medical device from a patient using a device-based detection algorithm. The physiological event detector uses an algorithm different from the device-based detection algorithm to generate one or more metrics including at least one entropy metric from the received information about the cardiac pause episode, and verify a presence or absence of cardiac pause in the device-detected cardiac pause episode using such metrics. The verified presence or absence of the cardiac pause may be presented to a user or a process to determine a medical condition, such as a risk of syncope in the patient.